NATALIE LINKOUS: Open Payments
NPI 1356945018 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,264 in 147 payments from 15 companies in 2025. Trend: 2023 $2,465 · 2024 $1,951 · 2025 $4,264
Food & beverage: $3,083Travel & lodging: $1,181
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 11 | $1,500 |
| Alkermes, Inc. | 27 | $485 |
| Axsome Therapeutics, Inc. | 13 | $406 |
| ABBVIE INC. | 39 | $344 |
| Otsuka America Pharmaceutical, Inc. | 18 | $333 |
| Supernus Pharmaceuticals, Inc. | 11 | $243 |
| Neurocrine BioSciences, Inc. | 7 | $243 |
| E.R. Squibb & Sons, L.L.C. | 5 | $214 |
| Vanda Pharmaceuticals Inc. | 5 | $179 |
| Neuronetics, Inc. | 1 | $121 |
Products named: SPRAVATO, Auvelity, LYBALVI, VRAYLAR, Qelbree, INGREZZA, COBENFY, REXULTI.
Industry payments across TN — which companies pay providers there.
